Impact of obesity on metabolic control in type 2 diabetes: Five-year trends of Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes (TEMD Obesity Study, 2017-2022)

Basit Öğe Kaydı
dc.authorid0000-0003-4934-7761
dc.authorid0000-0002-9309-7715
dc.authorid0000-0002-6866-2364
dc.authorid0000-0003-3431-0915
dc.authorid0000-0003-0650-3242
dc.authorid0000-0003-4867-3725
dc.authorid0000-0001-8613-1797
dc.authorid0000-0002-9637-6744
dc.contributor.authorKıyıcı, Sinem
dc.contributor.authorDemirci, İbrahim
dc.contributor.authorSönmez, Alper
dc.contributor.authorHaymana, Cem
dc.contributor.authorMert, Meral
dc.contributor.authorNuhoğlu, İrfan
dc.contributor.authorTaşçı, İlker
dc.contributor.authorSalman, Serpil
dc.contributor.authorSatman, İlhan
dc.contributor.authorBayram, Fahri
dc.date.accessioned2025-07-26T09:22:44Z
dc.date.available2025-07-26T09:22:44Z
dc.date.issued2025
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractBackground: Türkiye has the highest obesity prevalence in Europe. Obesity not only causes type 2 diabetes mellitus (T2DM) but also impairs glycemic control in patients with T2DM. There is insufficient information about the demographic and clinical differences between individuals with T2DM who are living with or without obesity. Objectives: The second TEMD survey across Türkiye investigated the latest overweight and obesity prevalence in patients with T2DM. The present study evaluated the five-year changes in the prevalence, factors associated with an obesity diagnosis and the association between obesity and metabolic control. Methods: Patients under follow-up in tertiary units specialized for diabetes care were consecutively enrolled. The sociodemographic, anthropometric, and clinical variables were recorded. Metabolic targets were defined as HbA1c <7%, home arterial blood pressure (ABP)<135/85 mmHg, or LDL-C<100 mg/dL or <70 mg/dL or <55 mg/dL according to the risk factors or complications of patients. Metabolic target attainment rates were investigated across normal-weight, overweight and obesity body mass index (BMI) classes. Results: The TEMD Obesity Study enrolled 4935 patients with T2DM (age 58.9±10.1 years; women 59.8%). The prevalence of overweight and obesity was 33.4% and 55.1%, respectively. Obesity was more frequent in women with T2DM than men (66.2% vs. 38.1%; p=<0.001). From 2017 to 2022, the obesity rate decreased from 59.0% to 55.1%, while the overweight rate increased from 31.0% to 33.4%. As BMI class increased, the achievement of three metabolic targets decreased while the incidence of microvascular complications rose. Significant associations were found between obesity and sociodemographic characteristics (age, sex, education level) and lifestyle measures (diet, exercise, smoking) in multivariable logistic regression analysis. Conclusion: The TEMD Obesity study showed a decrease in obesity rates among patients with T2DM between 2017 and 2022. Also, the findings suggest that obesity poses an important barrier to the achievement of metabolic goals.
dc.description.sponsorshipTEMD Obezite Araştırması, Türk Endokrinoloji ve Metabolizma Derneği tarafından finanse edilmiştir. The TEMD Obesity Study was funded by the Turkish Society of Endocrinology and Metabolism.
dc.identifier.citationKıyıcı, S., Demirci, İ., Sönmez, A., Haymana, C., Mert, M., Nuhoğlu, İ., Taşçı, İ., Salman, S., Satman, İ., & Bayram, F. (2025). Impact of obesity on metabolic control in type 2 diabetes: Five-year trends of Turkish nationwide survey of glycemic and other metabolic parameters of patients with diabetes (TEMD Obesity Study, 2017–2022). Obesity Facts, https://doi.org/10.1159/000547136
dc.identifier.doi10.1159/000547136
dc.identifier.issn1662-4033
dc.identifier.issn1662-4025
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1159/000547136
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1037
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.otherSCI-E - Science Citation Index Expanded
dc.institutionauthorSalman, Serpil
dc.institutionauthorid0000-0003-4867-3725
dc.language.isoen
dc.publisherS. Karger AG
dc.relation.ispartofObesity Facts
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectObesity
dc.subjectType 2 Diabetes
dc.subjectHbA1c
dc.subjectHypertension
dc.subjectDyslipidemia
dc.titleImpact of obesity on metabolic control in type 2 diabetes: Five-year trends of Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes (TEMD Obesity Study, 2017-2022)
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
1.99 MB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Bölümü Koleksiyonu